The outlook for antifungal prophylaxis in the compromised host.
D002177:Candidiasis / Q000517:prevention & control; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D007109:Immunity; D007654:Ketoconazole; D008825:Miconazole / Q000627:therapeutic use; D009181:Mycoses / Q000517:prevention & control*; D009369:Neoplasms / Q000150:complications; D009761:Nystatin / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use
D007093:Imidazoles; D010879:Piperazines; D009761:Nystatin; D008825:Miconazole; D007654:Ketoconazole